A framework for addressing structural uncertainty in decision models

Medical Decision Making

Volumn 31, Issue 4, 2011, Pages 662-674

  Jackson, Christopher H ^a   Bojke, Laura ^b   Thompson, Simon G ^a   Claxton, Karl ^b   Sharples, Linda D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Bayesian methods; elicitation; model averaging; probabilistic sensitivity analysis

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; HUMAN; QUALITY ADJUSTED LIFE YEAR; UNCERTAINTY;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; QUALITY-ADJUSTED LIFE YEARS; UNCERTAINTY;

EID: 79960522971     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X11406986     Document Type: Article

References (39)

1. Claxton K, Sculpher M, Drummond M. A rational framework for decision-making by the National Institute for Clinical Excellence (NICE). Lancet. 2002 ; 360 (9334). 711-5 (Pubitemid 35232343)
2. Guide to the Methods of Technology Appraisal. London: NICE ; 2008 :
3. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999 ; 18 (3). 341-64 (Pubitemid 29242816)
4. Bojke L, Claxton K, Sculpher M, Palmer S. Characterising structural uncertainty in decision analytic models: a review and application of methods. Value Health. 2009 ; 12 (5). 739-49
5. Russell LB. Comparing model structures in cost-effectiveness analysis. Med Decis Making. 2005 ; 25: 484-6
6. Claxton K, Sculpher M, McCabe C, et al. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ. 2005 ; 14 (4). 339-47 (Pubitemid 40514748)
7. Weinstein MC, Brien B, Hornberger J, et al. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices-Modeling studies. Value Health. 2003 ; 6 (1). 9-17 (Pubitemid 36228345)
8. Karnon J, Brennan A, Akehurst R. A critique and impact analysis of decision modeling assumptions. Med Decis Making. 2007 ; 27 (4). 491-9 (Pubitemid 47106936)
9. Kim LG, Thompson SG. Uncertainty and validation of health economic decision models. Health Econ. 2010 ; 19 (1). 43-55
10. Draper D. Assessment and propagation of model uncertainty (with discussion). J Roy Stat Soc B. 1995 ; 57 (1). 45-97
11. Clyde M, George EI. Model uncertainty. Stat Sci. 2004 ; 19 (1). 81-94 (Pubitemid 39056878)
12. Manning WG, Fryback DG, Weinstein MC Cost-Effectiveness in Health and Medicine. Gold MR Siegel JE Russell LB Weinstein MC, ed. New York: Oxford University Press ; 1996: 247-75.
13. Jackson CH, Sharples LD, Thompson SG. Structural and parameter uncertainty in Bayesian cost-effectiveness models. J Roy Stat Soc C Appl Stat. 2009 ; 59 (2). 233-53
14. Jackson CH, Thompson SG, Sharples LD. Accounting for uncertainty in health economic decision models by using model averaging. J Roy Stat Soc A Stat Soc. 2009 ; 172 (2). 383-404
15. Negrín MA, Váquez-Polo FJ. Incorporating model uncertainty in cost-effectiveness analysis: a Bayesian model averaging approach. J Health Econ. 2008 ; 27: 1250-9
16. Conigliani C, Tancredi A. A Bayesian model averaging approach for cost-effectiveness analyses. Health Econ. 2009 ; 18 (7). 807-21
17. Bojke L, Claxton K, Sculpher M, Palmer S, Abrams K. Eliciting distributions to populate decision-analytic models. Value Health. 2010 ; 13 (5). 557-64
18. Briggs A. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics. 2000 ; 17 (5). 479-500 (Pubitemid 30398806)
19. Briggs A, Sculpher M, Claxton K Decision Modelling for Health Economic Evaluation. Oxford, UK: Oxford University Press ; 2006 :
20. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996 ; 15 (4). 361-87 (Pubitemid 26072233)
21. Turner RM, Spiegelhalter DJ, Smith GCS, Thompson SG. Bias modelling in evidence synthesis. J Roy Stat Soc Stat Soc A. 2009 ; 172 (1). 21-47
22. Caldwell DM, Ades AE, Higgins JPT. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. Br Med J. 2005 ; 331: 897-900 (Pubitemid 41502718)
23. Karnon J. Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation. Health Econ. 2002 ; 12 (10). 837-48 (Pubitemid 37220634)
24. Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ. 2006 ; 15 (12). 1295-310 (Pubitemid 44941606)
25. Jones L, Griffin S, Palmer S, et al. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation. Health Technol Assess. 2004 ; 8 (38). iii 1 - iv 196
26. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996 ; 348: 1329-39
27. Diener HC, Forbes C, Riekkinen PJ, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2: Efficacy and safety data. J Neurol Sci. 1997 ; 151 (suppl 1). 1-61
28. Burnham KP, Anderson DR Model Selection and Multi-Model Inference: A Practical Information-Theoretic Approach. New York: Springer ; 2002 :
29. Akaike H. Information theory and an extension of the maximum likelihood principle. 2nd International Symposium on Information Theory ; 1973 ; 1973. 267.
30. Stinnett AA, Paltiel AD. Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means. Med Decis Making. 1997 ; 17 (4). 483-9 (Pubitemid 27444320)
31. Woolacott N, Bravo Vergel Y, Hawkins N, et al. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technol Assess. 2006 ; 10 (31). 1-258
32. Van Noortwijk JM, Dekker A, Cooke RM, Mazzuchi TA. Expert judgment in maintenance optimization. IEEE Trans Reliab. 1992 ; 41 (3). 427-32
33. Ibrekk H, Granger Morgan M. Graphical communication of uncertain quantities to nontechnical people. Risk Anal. 1987 ; 7: 519-29 (Pubitemid 18033524)
34. Cooke RM Experts in Uncertainty: Opinion and Subjective Probability in Science. Oxford, UK: Oxford University Press ; 1991 :
35. Genest C, Zidek JV. Combining probability distributions: a critique and an annotated bibliography (with discussion). Stat Sci. 1986 ; 1: 114-48
36. Jackson CH, Sharples LD, Thompson SG. Survival models in health economic evaluations: balancing fit and parsimony to improve prediction. Int J Biostat. 2010 ; 6 ( 1 ):
37. Demiris N, Sharples LD. Bayesian evidence synthesis to extrapolate survival estimates in cost-effectiveness studies. Stat Med. 2006 ; 25: 1960-75 (Pubitemid 43826846)
38. Spiegelhalter DJ, Best NG. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling. Stat Med. 2003 ; 22 (23). 3687-709 (Pubitemid 37483543)
39. Cooper NJ, Sutton AJ, Abrams KR, Turner D, Wailoo A. Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach. Health Econ. 2004 ; 13 (3). 203-26